Table 1 Characteristics and indications for MCE in the two groups (n = 293)
From: Magnetic-controlled capsule endoscopy performance in aging patients
Oldest (n = 128, 43.7%) | Older (n = 165, 56.3%) | P-value | |
|---|---|---|---|
Age, median (IQR) | 87.0 (84.0, 91.0) | 65.0 (62.0,74.0) | P < 0.001 |
Male/female, n | 109/19 | 127/38 | 0.079 |
BMI, mean ± SD, kg/m2 | 23.6 ± 3.4 | 24.8 ± 2.8 | P = 0.005 |
Comorbidity | |||
Coronary artery disease, n (%) | 49 (38.3) | 43 (26.1) | P = 0.025 |
Atrial fibrillation, n (%) | 11 (8.6) | 10 (6.1) | P = 0.404 |
Diabetes mellitus, n (%) | 36 (28.1) | 35 (21.2) | P = 0.171 |
Antithrombotic therapy history, n (%) | 81 (64.8) | 78 (47.3) | P = 0.003 |
Indication for MCE | |||
GI bleeding/iron deficiency anemia, n (%) | 22 (17.2) | 13 (7.9) | P = 0.015 |
Dyspepsia, n (%) | 24 (18.8) | 58 (35.2) | P = 0.002 |
Ulcer, n (%) | 3 (2.3) | 5 (3.0) | P = 1.000 |
Poor appetite, n (%) | 8 (6.3) | 1 (0.6) | P = 0.012 |
Acid reflux, n (%) | 8 (6.3) | 8 (4.8) | P = 0.600 |
Elevated tumor markers for gastrointestinal malignancies, n (%) | 4 (3.1) | 2 (1.2) | P = 0.409 |
GI injury assessment, n (%) | 35 (27.3) | 42 (25.5) | P = 0.789 |
Physical examination. n (%) | 18 (14.1) | 25 (15.2) | P = 0.868 |
Others*, n (%) | 4 (3.1) | 5 (3.0) | P = 1.000 |